EPSRC Centre for Doctoral Training in Emergent Macromolecular Therapies
The mission of the UCL The Centre for Doctoral Training in Emergent Macromolecular Therapies is to train the bioprocess engineering research leaders of the future who will deliver translation of new scientific advances into safely produced, more selective, therapies for currently intractable conditions at affordable costs.
The CDT is funded by the Engineering and Physical Sciences Research Council (EPSRC) and will award 7 PhD studentships a year until 2018. Each studentship is for four years and will be undertaken at UCL or one of several CDT collaborating universities. All researchers undertake 18 weeks of taught training which includes residential Summer and Autumn Camps.
Our research is at the cutting edge of process engineering and is aimed at developing new and improved processes for the next generation of biopharmaceuticals. The research is aligned to the Centre for Innovative Manufacture of Emergent Macromolecular Therapies which is also hosted at UCL. This gives all CDT students access to a consortium of key industry leaders, and an opportunity to present their work to the wider Bioprocessing community.